National Heart, Lung, and Blood Institute in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, (MD): National Heart, Lung, and Blood Institute; 1998.
Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev 2005;6: 117-21.
Ekman P. BPH epidemiology and risk factors. Prostate Suppl 1989; 2: 23-31.
Park YH, Chung MK. The prevalence of clinical benign prostatic hyperplasia and lower urinary tract symptoms in South-East Korea: a communitybased study. J Pusan Natl Univ Hosp 2001; 9: 141-57.
Lee MW, Lee KS. The prevalence of benign prostatic hyperplasiain self-referral populations over aged 50. Korean J Urol 1996; 37: 263-7.
Soygür T, Küpeli B, Aydos K, Küpeli S, Arikan N, Müftüoğlu YZ. Effect of obesity on prostatic hyperplasia: its relation to sex steroid levels. Int Urol Nephrol 1996; 28: 55-9.
Daniell HW. Larger prostatic adenomas in obese men with no associated increase in obstructive uropathy. J Urol 1993; 149: 315-7.
Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994; 140:989-1002.
Caine M, Raz S, Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 1975; 47: 193202.
Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991; 17: 669-77.
Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-8.
Pollack HM. Imaging of the prostate gland. Eur Urol 1991; 20 Suppl 1: 50-8.
Collins GN, Raab GM, Hehir M, King B, Garraway WM. Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume. Ultrasound Med Biol 1995; 21: 1101-5.
Hastak SM, Gammelgaard J, Holm HH. Transrectal ultrasonic volume determination of the prostate--a preoperative and postoperative study. J Urol 1982; 127: 1115-8.
Jones DR, Roberts EE, Griffiths GJ, Parkinson MC, Evans KT, Peeling WB. Assessment of volume measurement of the prostate using per-rectal ultrasonography. Br J Urol 1989; 64: 493-5.
Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 469-71.
Garraway WM, Russell EB, Lee RJ, Collins GN, McKelvie GB, Hehir M, et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993; 43: 31821.
Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 2008; 87: 1455-63.
World Health Organization. Western Pacific Region. International Association for the Study of Obesity. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia PtyLimited;2000.
Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 495-507.
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9.
Boyle P, McGinn R, Maisonneuve P, La Vecchia C. Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed. Eur Urol 1991; 20 Suppl 1: 3-10.
Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 461-75.
Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 2006; 14: 172-9.
Jung JH, Ahn SV, Song JM, Chang SJ, Kim KJ, Kwon SW, et al. Obesity as a risk factor for prostatic enlargement: a retrospective cohort study in Korea. Int Neurourol J 2016; 20: 321-8.
Sidney S, Quesenberry C Jr, Sadler MC, Lydick EG, Guess HA, Cattolica EV. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology 1991; 38(1 Suppl): 13-9.
Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 1999; 149: 106-15.
Guess HA. Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 1992; 14: 131-53.
Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 2002; 75: 689-97.
Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998;158: 2349-56.